biote BTMD 深 滬
等待開盤 10-07 09:30:00 美东时间
1.14
+0.020
+1.79%
華盛通- 最 高1.25
- 今 開1.12
- 成交量 23.13万股
- 最 低 1.12
- 昨 收 1.12
- 總市值 4095.73万
- 52周最高 3.26
- 市盈率 靜 1.55
- 換手率 0.64%
- 52周最低 1.10
- 委 比 89.69%
- 總股本 3592.75万
- 歷史最高 12.08
- 量 比 1.96
- 振 幅 11.61%
- 歷史最低 1.10
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Top 10 Q3 insider stock sellers led by Nvidia’s Stevens, Jeff Bezos
Billionaire venture capitalist and Nvidia (NVDA) director Mark Stevens led insider selling in the third quarter, as the chipmaker’s valuation neared its cheapest level in more than a decade, with othe...
今天 18:00
Eli Lilly-backed TRex Bio targets up to $133M in U.S. IPO
Anti-inflammatory drug developer TRex Bio (TRXB), whose backers include Eli Lilly (LLY), disclosed additional details regarding its upcoming U.S. listing this week, seeking to raise up to $133M from a...
10-06 23:49
BridgeBio nabs Priority Review for infigratinib for achondroplasia
The US FDA accepted BridgeBio Pharma's (BBIO) NDA for oral infigratinib for achondroplasia and granted the application Priority Review. The FDA action date is Feb. 4, 2027. The NDA is supported by res...
10-06 22:53
Oppenheimer's fall 2026 SMID-cap ideas include four Strong Buy stocks
As investors look beyond the largest companies for potential opportunities, Oppenheimer Equity Research has updated its list of SMID-cap ideas for Fall 2026, highlighting a group of companies across t...
10-06 21:09
Lexicon Pharmaceuticals Q2 2026 Earnings Call: Complete Transcript
Lexicon Pharmaceuticals (NASDAQ:LXRX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzinga.com/apis/ for a consul...
10-06 15:51
Most shorted stocks on Wall Street
As October begins, investors are keeping a close eye on heavily shorted stocks that could see heightened volatility. The latest mid- to mega-cap screen shows 39 stocks with short interest above 20% of...
10-05 21:35
Why is Alector Stock (ALEC) 60% Higher Today?
Shares in U.S. biotech firm Alector ($ALEC) surged 60% in pre-market trading to...
10-05 21:18
Cathie Wood's Ark Invest weekly recap: loads up on Nvidia, Intellia; pares AMD
Cathie Wood’s Ark Invest stepped up its semiconductor, biotechnology and technology exposure during the week ended October 2, with Nvidia (NVDA) and Intellia Therapeutics (NTLA) leading its buying act...
10-05 18:47
FDA approves additional U.S. manufacturing capacity for SIMLANDI®, Alvotech’s biosimilar to Humira®
Alvotech announced FDA approval of a supplement to the BLA for AVT02 (adalimumab-ryvk), allowing production of the drug substance in a second suite at its Reykjavik facility. This doubles manufacturing capacity for U.S. supply and confirms resolution of FDA inspection-related matters. The approval enhances flexibility and capacity for AVT02 production, supporting commercial supply to the U.S. market. The FDA's July 2026 inspection closure with a ...
10-05 08:00
Moderna, Illumina lead healthcare gains in September as medtech drags
Healthcare stocks underperformed the broader market in September, with the Health Care Select Sector SPDR Fund (XLV) falling 1.89% while the SPDR S&P 500 ETF Trust (SPY) gained 0.27%. The sector's wea...
10-03 23:05
